Elixir Pharmaceuticals, Inc. — Form D

Elixir Pharmaceuticals, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2009-05-28. The offering totals $25.0M, of which $12.0M was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2009-05-28
Form: D
Accession: 0001175784-09-000003
Industry: Pharmaceuticals
Exemptions: 06
Total offering: $25.0M
Amount sold: $12.0M
Remaining: $13.0M
Minimum investment: $1
Investors: 36
Date of first sale: 2009-05-15
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-44911

Issuer

Name: Elixir Pharmaceuticals, Inc.
CIK: 0001175784
Entity type: Corporation
Jurisdiction: DE
Address: 12 EMILY STREET, CAMBRIDGE, MA, 02139
Phone: 617-995-7000

Officers, directors & promoters (10)

Name	Role	Location
Vernon Cassin	Director	Cambridge, MA
Ansbert Gadicke	Director	Morristown, NJ
Kenneth Greenberg	Director	South San Francisco, CA
Vaughn M Kailian	Director	Boston, MA
DION MADSEN	Director	VANCOUVER, A1
Paul M Martha	Director	Cambridge, MA
Peter S DiStefano	Executive Officer	Cambridge, MA
Robert Kriebel	Executive Officer	Cambridge, MA
Paul M Martha	Executive Officer	Cambridge, MA
Karen Roberts	Executive Officer	Cambridge, MA

More